2020 Abstract Award Recipients

AASLD Foundation Abstract Awards recognize excellence and promote the professional development of young investigators.

Congratulations to the 61 investigators who presented their award-winning abstracts at the 2020 TLMdX. 2021 recipients will be announced in September.

Meet the Awardees

• Advanced Practice Providers Awards
• Early Career Investigator Awards in Basic Science
• Early Career Investigator Award in Clinical/Translational Science
• Fellow Research Award
• International Early Career Investigator Award
• Liver Transplant & Hepatobiliary Surgery Fellow Award
• Leonard B. Seeff Award for Outstanding Research by an Early Career Investigator
• Maribel Rodriguez-Torres Memorial Travel Award
• Pediatric Research Award
• Resident Research Award
• Rosalyn and Leo Fried Memorial Travel Award
• Student Research Award
• Professor Margit Hamosh Memorial Travel Award
• The Professor Mindie H. Nguyen Award for Outstanding Clinical Research by an Early Career Investigator
• PSC Partners Seeking a Cure Award

Erin Parkinson, MS, APRN-C
Tampa General Medical Group
Abstract Title: HEPATITIS C VIREMIC ORGANS TRANSPLANTED INTO NON-VIREMIC RECIPIENTS; A REAL WORLD NURSE PRACTITIONER LED CLINIC
Mentor: Christopher M. Albers, MD
Category: Advanced Practice Providers; Practice Issues

Lindsay N. Yoder, MPAS, PA-C
Indiana University School of Medicine
Abstract Title: A POST-DISCHARGE TRANSITION CLINIC FOR PATIENTS WITH LIVER DISEASE REDUCES HOSPITAL READMISSIONS
Mentor: Eric S. Orman, MD and Raj K. Vuppalanchi, MD, FAASLD
Category: Health Services and Public Health Research; Health Care Delivery/Access/Quality/Equity

Stephen R. Atkinson, MD, PhD, MRCP
Imperial College London and University of Pittsburgh
Abstract Title: HEPATIC SINGLE CELL SEQUENCING REVEALS A BILIARY PROGENITOR-LIKE TRANSCRIPTIONAL PROGRAM IN HEPATOCYTES IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS
Mentor: Ramon Bataller, MD, PhD
Category: Alcohol-Associated Liver Diseases: Clinical and Experimental

Hiroaki Ayabe, PhD
Cincinnati Children's Hospital Medical Center
Abstract Title: 3-DIMENSIONAL ARCHITECTURE OF MULTILINEAGE BILIARY ORGANOIDS FROM CHILDREN WITH BILIARY ATRESIA EXHIBIT STRUCTURAL DEFICITS IN EPITHELIUM AND PERIBILIARY GLANDS
Mentor: Jorge A. Bezerra, MD, FAASLD
Category: Pediatric Hepatology; Biliary Atresia and Cholestasis

Samuel Buchl, BA
Mayo Clinic Rochester
Abstract Title: TNIK IS A NOVEL PROCOLLAGEN I TRAFFICKING PROTEIN THAT CAN BE TARGETED IN VIVO TO LIMIT FIBROSIS
Mentor: Jessica L. Maiers, PhD
Category: Liver Fibrogenesis and Non-Parenchymal Cell Biology; Basic Fibrosis Research and Stellate Cell Biology

Wei Chen, PhD
University of Illinois at Chicago
Abstract Title: MATRISOME GENES FROM HEPATITIS B-INDUCED HEPATOCELLULAR CARCINOMA UNVEILED
Mentor: Natalia Nieto, PhD
Category: Genomics and Precision Medicine; Genomics and Precision Medicine

Sukanta Das, MSc, PhD
University of Illinois at Chicago
Abstract Title: THE INTEGRATED ‘MULTIOMICS’ LANDSCAPE DURING PROGRESSION AND RESOLUTION OF ALCOHOLIC LIVER DISEASE
Mentor: Natalia Nieto, PhD
Category: Alcohol-Associated Liver Diseases: Clinical and Experimental

Vikas Gupta, MD, PhD
Weill Cornell Medical College
Abstract Title: A NICHE OF Gli1+ PERIBILIARY MESENCHYMAL CELLS CONTRIBUTE TO CHOLESTATIC FIBROSIS
Category: Liver Fibrogenesis and Non-Parenchymal Cell Biology; Basic Fibrosis Research and Stellate Cell Biology

Rakesh Kumar Jagdish, MD, MBBS
Institute of Liver and Biliary Sciences
Abstract Title: BIOENERGETIC DYSFUNCTION OF MONOCYTES IS ASSOCIATED WITH INCREASED INCIDENCE OF SEPSIS AND MORTALITY IN ACUTE-ON -CHRONIC LIVER FAILURE
Mentor: Shiv Kumar Sarin, MD, FAASLD
Category: Inflammation and Immunobiology; Mechanisms of Injury

Enis Kostallari, PhD
Mayo Clinic Rochester
Abstract Title: SINGLE CELL RNA SEQUENCING REVEALS FHL2 AS A STIFFNESS-REGULATED MOLECULE TO PROMOTE LIVER FIBROSIS
Mentor: Vijay H. Shah, MD, FAASLD
Category: Liver Fibrogenesis and Non-Parenchymal Cell Biology; Basic Fibrosis Research and Stellate Cell Biology

Yuki Makino, MD, PhD
Osaka University
Abstract Title: OVER-ACTIVATION OF TUMOR SUPPRESSOR p53 IN HEPATOCYTES PARADOXICALLY PROMOTES HEPATOCARCINOGENESIS DERIVED FROM HEPATIC PROGENITOR CELLS
Mentor: Tetsuo Takehara, MD, PhD, FAASLD
Category: Hepatobiliary Neoplasia; Experimental Hepatocarcinogenesis

Yuta Myojin, MD
Osaka University
Abstract Title: GDF15 SECRETED BY HEPATIC STELLATE CELLS ACCELERATES HCC PROGRESSION IN AN AUTOPHAGY-DEPENDENT MANNER
Mentor: Tetsuo Takehara, MD, PhD, FAASLD
Category: Hepatobiliary Neoplasia; Experimental Hepatocarcinogenesis

Takuto Nosaka, MD, PhD
University of Fukui
Abstract Title: IDENTIFICATION OF IFN-GAMMA MEDIATED REGULATORY MOLECULES FOR HEPATITIS B VIRUS CLONES IN PRIMARY HUMAN HEPATOCYTES
Mentor: Yasunari Nakamoto, MD, PhD
Category: Hepatitis B; Virology, Pathogenesis, and Immunology

Sophia Pantasis
ETH Zürich
Abstract Title: HEPATOCYTE-DERIVED SECRETED TYROSINE KINASE VLK HAS A POTENTIAL HEPATO-PROTECTIVE ROLE
Mentor: Prof. Sabine Werner and Dr. Mattia R. Bordoli
Category: Liver Fibrogenesis and Non-Parenchymal Cell Biology; Basic Fibrosis Research and Stellate Cell Biology

Milad Rezvani, MD, PhD
Cincinnati Children's Hospital
Abstract Title: LIVER EPITHELIAL ORGANOID CO-CULTURE WITH HUMAN STELLATE CELLS INDUCES TRANSCRIPTIONAL SIGNATURES RELEVANT FOR DUCTULAR REACTION PHENOTYPES
Mentor: Wolfram Goessling, MD, PhD, FAASLD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis; Cholangiocyte Biology

Marcelle Ribeiro, PhD
Beth Israel Deaconess Medical Center - Harvard Medical School
Abstract Title: ASC SPECKS REQUIRE NLRP3 TO AMPLIFY INFLAMMATION IN ALCOHOLIC HEPATITIS IN A CELL-SPECIFIC MANNER
Mentor: Gyongyi Szabo, MD, PhD, FAASLD, AGAF, FACP
Category: Inflammation and Immunobiology; Innate Immunity

Keisaku Sato, PhD
Indiana University
Abstract Title: CHOLANGIOCYTES INDUCE ACTIVATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF HEPATIC STELLATE CELLS BY DELIVERING MICRORNAS VIA EXTRACELLULAR VESICLES
Mentor: Gianfranco Alpini, PhD, FAASLD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis

Yun-Ling Tai
Virginia Commonwealth University
Abstract Title: HEPATIC DEFICIENCY OF SPHINGOSINE KINASE 2 EXACERBATES BILE DUCT LIGATION-INDUCED CHOLESTATIC LIVER INJURY
Mentor: Huiping Zhou, PhD, FAASLD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis

Lin Wang, MD, PhD
Fourth Military Medical University
Abstract Title: SINGLE-CELL RNA-SEQUENCING AND LINEAGE-TRACING REVEAL LIVER ENDOTHELIA AS DOMINANT CONTRIBUTORS TO SINUSOIDAL FIBROGENESIS
Category: Liver Fibrogenesis and Non-Parenchymal Cell Biology; Basic Fibrosis Research and Stellate Cell Biology

Nan Wu, MD
Indiana University
Abstract Title: MELATONIN RECEPTORS, MT1 AND MT2, DIFFERENTIALLY REGULATE BILIARY DAMAGE AND LIVER FIBROSIS IN BILE DUCT LIGATED (BDL) MICE THROUGH MODULATION OF CAMP SIGNALING
Mentor: Gianfranco Alpini, PhD, FAASLD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis

Yang Zhang, PhD
Wayne State University
Abstract Title: IMPACT OF THE PNPLA3 I148M POLYMORPHISM ON GUT MICROBIOTA
Mentor: Wanqing Liu, PhD
Category: Gut Liver Axis and Microbiome

Tianhao Zhou, PhD
Indiana University
Abstract Title: mtDNA RELEASED BY CHOLANGIOCYTES PROMOTES STING ACTIVATION AND FIBROTIC REACTION
Mentor: Gianfranco Alpini, PhD, FAASLD and Shannon Glaser, PhD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis

Venkata Boddupalli, PhD
Yale School of Medicine
Abstract Title: DISSECTING THE IMMUNE LANDSCAPE OF HUMAN HCC ACROSS VARIED TUMOR TYPES AND LIVER DISEASE ETIOLOGIES
Mentor: Tamar H. Taddei, MD, FAASLD and Pramod K. Mistry, MD, PhD, FAASLD, FRCP
Category: Inflammation and Immunobiology; Adaptive Immunity

Ciro Celsa, MD
University of Palermo
Abstract Title: SEQUENTIAL SYSTEMIC THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN THE ERA OF IMMUNOTHERAPY: WHAT COMES NEXT?
Mentor: Calogero Cammà, MD
Category: Hepatobiliary Neoplasia; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

Curtis Lee Gabriel, MD, PhD
Vanderbilt University Medical Center
Abstract Title: HIV-INFECTED PERSONS WITH HEPATIC STEATOSIS HAVE A UNIQUE PLASMA LIPIDOME
Mentor: John Koethe, MD, MSCI and Jane Ferguson, PhD
Category: NAFLD and NASH; Experimental: Clinical

Christina S. Gainey, MD
LAC+USC Medical Center, University of Southern California
Abstract Title: STRIKING RURAL-URBAN DISPARITIES IN HEPATOCELLULAR CARCINOMA TRENDS IN THE UNITED STATES, 1995-2016
Mentor: Kali Zhou, MD and Norah Terrault, MD, MPH, FAASLD
Category: Hepatobiliary Neoplasia; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

Grishma Hirode, MSc
University Health Network, Toronto Centre for Liver Disease
Abstract Title: HBsAg LOSS IS HIGHER AMONG CAUCASIANS COMPARED TO ASIANS AFTER STOPPING NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A LARGE, GLOBAL, MULTI-ETHNIC COHORT OF PATIENTS WITH CHRONIC HEPATITIS B (RETRACT-B STUDY)
Mentor: Harry L.A. Janssen, MD, PhD, FAASLD
Category: Hepatitis B; Therapeutics: Approved Agents

Helenie Kefalakes, MD
National Institutes of Health
Abstract Title: BYSTANDER CELLS CONTRIBUTE TO LIVER DISEASE PATHOGENESIS IN CHRONIC HEPATITIS D VIRUS INFECTION
Mentor: Barbara Rehermann, MD, FAASLD
Category: Hepatitis – Other Infections

Alyssa Kriegermeier, MD
Ann and Robert H. Lurie Children's Hospital of Chicago
Abstract Title: LIVER-SPECIFIC DELETION OF X-BOX BINDING PROTEIN 1 (XBP1), BUT NOT INOSITOL-REQUIRING ENZYME 1α (IRE1α), REDUCES LIVER INJURY AND FIBROSIS IN Mdr2(-/-) MICE
Mentor: Richard Green, MD, FAASLD
Category: Pediatric Hepatology; Biliary Atresia and Cholestasis

Tatyana Kushner, MD, MSCE
Icahn School of Medicine at Mount Sinai
Abstract Title: LIVER TRANSPLANTATION FOR HEPATITIS DELTA IN THE UNITES STATES
Mentor: Behnam Saberi, MD
Category: Hepatitis B; Epidemiology, Prevention, Natural History

David Uihwan Lee, MD
Tufts Medical Center
Abstract Title: THE EFFECT OF MALNUTRITION ON THE INFECTIOUS OUTCOMES OF HOSPITALIZED PATIENTS WITH ALCOHOLIC HEPATITIS
Mentor: Raffi Karagozian, MD
Category: Alcohol-Associated Liver Diseases: Clinical and Experimental

Grazia Pennisi
University of Palermo
Abstract Title: GEMS, A GENETIC METABOLIC STAGING PREDICTING THE OUTCOME OF NON-ALCOHOLIC FATTY LIVER DISEASE
Mentor: Salvatore Petta, MD
Category: NAFLD and NASH; Diagnostics and Biomarkers

Kamron Pourmand, MD
Icahn School of Medicine at Mount Sinai
Abstract Title: BURNOUT AMONG TRANSPLANT HEPATOLOGISTS: A NATIONAL SURVEY
Category: Health Services and Public Health Research; Health Care Delivery/Access/Quality/Equity

Russell Rosenblatt, MD, MS
Weill Cornell Medicine
Abstract Title: MULTICENTER CONSORTIUM TO INVESTIGATE RISK FACTORS OF INFECTIONS WITH MULTIDRUG RESISTANT ORGANISMS IN LIVER TRANSPLANT RECIPIENTS
Mentor: Elizabeth Verna, MD, MS
Category: Liver Transplantation and Liver Surgery; Immunosuppression, Outcomes, Complications

Pablo Solis-Muñoz, PhD
Infanta Elena University Hospital
Abstract Title: MITOCHONDRIAL RESPIRATORY CHAIN DISFUNCTION PREDICTS CORTICOID RESPONSE AND MORTALITY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS
Mentor: Jose A. Solis-Herruzo, PhD, FAASLD
Category: Alcohol-Associated Liver Diseases: Clinical and Experimental

Milan Sonneveld, PhD
Erasmus University Medical Center
Abstract Title: PREDICTION OF SUSTAINED RESPONSE AFTER NUCLEO(S)TIDE ANALOGUE CESSATION USING HBSAG AND HBCRAG LEVELS – A MULTICENTER STUDY (CREATE)
Mentor: Robert A. De Man, MD, PhD
Category: Hepatitis B; Therapeutics: Approved Agents

Lena Stockhoff, MSc
Hannover Medical School
Abstract Title: LOW SERUM CHOLINESTERASE PREDICTS COMPLICATIONS AND MORTALITY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN PATIENTS WITH LIVER CIRRHOSIS
Mentor: Benjamin Maasoumy
Category: Portal Hypertension and Other Complications of Cirrhosis; Ascites, Renal Dysfunction, and Hepatorenal Syndrome

Sonu Subudhi, MBBS, PhD
Massachusetts General Hospital
Abstract Title: CHARACTERISTIC GENE EXPRESSION PATTERNS IN WHOLE LIVER TISSUE ASSOCIATED WITH DISTINCT STATES OF NAFLD
Mentor: Georg M. Lauer, MD, PhD
Category: NAFLD and NASH; Experimental: Clinical

Sharad Wadhwani, MD, MPH
University of California, San Francisco
Abstract Title: CENTER-LEVEL VARIATION IN LONG-TERM OUTCOMES FOR CHILDREN UNDERGOING LIVER TRANSPLANTATION—DOES A CHILD’S HOME NEIGHBORHOOD MATTER?
Mentor: Jennifer Lai, MD, MBA
Category: Health Services and Public Health Research; Health Care Delivery/Access/Quality/Equity

Heng Yao, PhD
The First Affiliated Hospital, Zhejiang University School of Medicine
Abstract Title: RNA AND SMALL RNA PROFILING OF PERIPHERAL BLOOD MONONUCLEAR CELLS REVEALS REGULATORY NETWORKS IN EMT-INDUCED FIBROGENESIS DURING THE PROGRESSION OF HEPATITIS B VIRUS-RELATED LIVER CIRRHOSIS
Mentor: Jun Li, PhD
Category: Hepatitis B; Virology, Pathogenesis, and Immunology

Terry Cheuk-Fung Yip, PhD
The Chinese University of Hong Kong
Abstract Title: LIVER ENZYME ELEVATION AND ACUTE LIVER INJURY ARE INDEPENDENTLY ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH COVID-19: A TERRITORY-WIDE COHORT STUDY OF 1,040 PATIENTS IN HONG KONG
Mentor: Grace Lai-Hung Wong, MD
Category: COVID-19 and the Liver; Clinical/Translational

Kali Zhou, MD, MAS
University of Southern California
Abstract Title: POPULATION-BASED GEOGRAPHIC HOTSPOT DETECTION OF LATE STAGE HEPATOCELLULAR CARCINOMA: NOVEL APPROACH TO CANCER CONTROL
Category: Health Services and Public Health Research; Health Care Delivery/Access/Quality/Equity

Nikhilesh Ray Mazumder, MD, MPH
Northwestern University
Abstract Title: BLACK PATIENTS WITH CIRRHOSIS HAVE WORSE OUTCOMES: RESULTS FROM A METROPOLITAN COHORT STUDY
Mentor: Daniela P. Ladner MD, MPH
Category: Health Services and Public Health Research; Health Care Delivery/Access/Quality/Equity

Alex González
Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán
Abstract Title: CHANGING TRENDS IN ETIOLOGY-BASED CHRONIC LIVER DISEASE FROM 2000 THROUGH 2019 IN MEXICO: MULTICENTER STUDY
Mentor: Dr. Ignacio García Juárez
Category: Health Services and Public Health Research; Health Care Delivery/Access/Quality/Equity

Louise China, PhD, MRCP
University College London & The Royal Free Hospital
Abstract Title: TARGETED ALBUMIN INFUSIONS IN HOSPITALISED ACUTELY DECOMPENSATED CIRRHOSIS PATIENTS HAVE NO EFFECT ON MARKERS OF SYSTEMIC INFLAMMATION NOR EX VIVO IMMUNE FUNCTION
Mentor: Alastair O'Brien, PhD, FRCP
Category: Portal Hypertension and Other Complications of Cirrhosis; Infections and Acute on Chronic Liver Failure

Dinesh Mani Tripathi, PhD
Institute of Liver and Biliary Sciences
Abstract Title: FENRETINIDE (4-HPR), AN ORPHAN NUCLEAR RECEPTOR NR4A1 MODULATOR AMELIORATES PORTAL PRESSURE AND REDUCES LIVER FIBROSIS PRE CLINICALLY: A NOVEL KEY REGULATOR OF HEPATIC STELLATE CELL ACTIVATION
Mentor: Shiv Kumar Sarin, MD, FAASLD
Category: Portal Hypertension and Other Complications of Cirrhosis; Experimental

Sarim Yousuf
Ziauddin University
Abstract Title: COPPER DEFICIENCY IS AN INDEPENDENT RISK FACTOR FOR DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS
Mentor: Lei Yu, MD
Category: Portal Hypertension and Other Complications of Cirrhosis; Encephalopathy and Other Complications

Qing-Lei Zeng, MD
The First Affiliated Hospital of Zhengzhou University
Abstract Title: TENOFOVIR ALAFENAMIDE TO PREVENT PERINATAL HEPATITIS B TRANSMISSION IN MOTHERS WITH HIGH VIRAL LOAD: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY
Mentor: Fu-Sheng Wang, MD, PhD, and Zu-Jiang Yu, MD, PhD
Category: Hepatitis B; Epidemiology, Prevention, Natural History

Benedikt Kaufmann, MD
University of California San Diego
Abstract Title: ROLE OF NEUTROPHIL-SPECIFIC NLRP3 ACTIVATION ON LIVER PATHOBIOLOGY: DISSOCIATION BETWEEN LIVER INFLAMMATION AND COLLAGEN TURNOVER
Mentor: Ariel E. Feldstein, MD
Category: Inflammation and Immunobiology; Animal Models

Siavash Raigani, MD
Massachusetts General Hospital
Abstract Title: NORMOTHERMIC MACHINE PERFUSION OF DISCARDED HUMAN LIVERS ALLEVIATES ISCHEMIA-REPERFUSION INJURY AND PROMOTES REGENERATIVE PATHWAYS
Mentor: Heidi Yeh, MD
Category: Liver Transplantation and Liver Surgery; Cellular Immunobiology, Preservation, and Cell Transplantation

Junkai Yan, PhD
Virginia Commonwealth University
Abstract Title: SPHINGOSINE-1 PHOSPHATE RECEPTOR 2-INDUCED Lin28a PROMOTES DUCTULAR REACTION IN CHOLESTATIC LIVER DISEASES
Mentor: Huiping Zhou, PhD, FAASLD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis

Sara Vega, PhD
Las Palmas de Gran Canaria University
Abstract Title: IMPACT OF SUSTAINED VIROLOGIC RESPONSE (SVR) ON THE LIPID PROFILE AND CARDIOVASCULAR RISK OF PATIENTS INFECTED WITH CHRONIC HEPATITIS C VIRUS (HCV) TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS)
Mentor: J. Rafael Granados, MD
Category: Hepatitis C; Therapies: General Populations

Astha Malik, PhD
Cincinnati Children's Hospital Medical Center
Abstract Title: ACTIVATION OF THE BILE ACID RECEPTOR TGR5 ON MACROPHAGES INDUCES TGFB SIGNALING AND PROMOTES FIBROSIS IN MURINE SCLEROSING CHOLANGITIS
Mentor: Alexander Miethke, MD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis

Rabab O. Ali, MD
Duke University
Abstract Title: EXPLORING THE PORTAL VEIN TO UNDERSTAND THE ALTERATIONS IN HEPATIC AND MICROBIAL GENE EXPRESSION IN CHRONIC HCV ASSOCIATED CIRRHOSIS
Mentor: Theo Heller, MD
Category: Gut Liver Axis and Microbiome

Monica Akram
German University in Cairo
Abstract Title: VIRTUAL SCREENING AND BIOLOGICAL EVALUATION OF POTENTIAL PD-1/PD-L1 IMMUNE CHECKPOINT INHIBITORS AS IMMUNOMODULATORS AND ANTI-HEPATOCELLULAR CARCINOMA AGENTS
Mentor: Hend M. El Tayebi, PhD, MSc
Category: Cell and Molecular Biology; Gene Expression and Therapy

Maya Kahan-Hanum, PhD
Weizmann Institute of Science, Israel
Abstract Title: BROAD HOST RANGE BACTERIOPHAGE FOR REDUCTION OF KLEBSIELLA PNEUMONIAE AS POTENTIAL THERAPY IN PRIMARY SCLEROSING CHOLANGITIS
Mentor: Prof. Ehud Shapiro
Category: Human Cholestatic and Autoimmune Liver Diseases; PBC/PSC and Other Cholestatic Disease

Nia Adeniji, M.Eng.
Stanford University, School of Medicine
Abstract Title: PREDICTORS OF OUTCOMES OF COVID-19 IN PATIENTS WITH CHRONIC LIVER DISEASE: US MULTI-CENTER STUDY
Mentor: Renumathy Dhanasekaran, MD
Category: COVID-19 and the Liver; Clinical/Translational

Won-Mook Choi, MD, PhD
Asan Medical Center, University of Ulsan College of Medicine
Abstract Title: ASSOCIATION OF ASPIRIN AND STATIN USE WITH HEPATOCELLULAR CARCINOMA RISK IN TREATMENT-NAÏVE NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B
Mentor: Young-Suk Lim, MD, PhD
Category: Hepatobiliary Neoplasia; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

Sukriti Baweja, PhD
Institute of Liver and Biliary Sciences
Abstract Title: LOSS OF SPHINGOSINE-1-PHOSPHATE PREDICTS SEVERE INTRAPULMONARY SHUNTING AND HEPATO-PULMONARY SYNDROME IN PATIENTS WITH CIRRHOSIS
Mentor: Shiv Kumar Sarin, MD, FAASLD
Category: Portal Hypertension and Other Complications of Cirrhosis; Experimental

Akash Roy, MBBS, MD
Post Graduate Institute of Medical Institute and Research
Abstract Title: SINGLE SESSION FECAL MICROBIOTA TRANSPLANTATION IN DECOMPENSATED CIRRHOSIS: AN INITIAL EXPERIENCE OF CLINICAL ENDPOINTS
Mentor: Radha K. Dhiman, MD, DM, FACG, FRCP, FAASLD
Category: Gut Liver Axis and Microbiome

Vik Meadows
Abstract Title: DEPLETION OF HISTAMINE REDUCES HEPATIC AND INTESTINAL MAST CELL ACTIVATION AND REGULATES BILE ACID SIGNALING DURING PSC
Mentor: Heather L. Francis, PhD, FAASLD
Category: Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis